Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
JNJ-75220795
DRUG
2 trials
Sponsors
Janssen Research & Development, LLC
, Janssen Pharmaceutical K.K.
Conditions
Fatty Liver
Fatty Liver Disease
Phase 1
A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795
Completed
NCT04844450
Janssen Research & Development, LLC
Fatty Liver Disease
Start: 2021-04-29
End: 2023-03-31
Updated: 2025-03-30
A Study of JNJ-75220795 in Japanese Participants
Terminated
NCT05039710
Janssen Pharmaceutical K.K.
Fatty Liver
Start: 2021-11-08
End: 2023-02-17
Updated: 2025-08-15
Related Papers
Association Between PNPLA3 Inhibition and Gout: A Drug Target Mendelian Randomization Study.
2025-08-20